A 22-year-old female college student presents to the university health clinic reporting recurrent, unexpected episodes of intense fear. During these episodes, she experiences palpitations, diaphoresis, shortness of breath, and a profound fear of losing control. The episodes peak within 10 minutes and have occurred four times in the past month. She now actively avoids the campus library, where two of the episodes occurred, fearing she will have another attack and be unable to escape. Her medical history is significant for a hospitalization one year ago for a 3-week period of severely decreased need for sleep, pressured speech, and grandiose delusions involving a belief that she was a prophet chosen to solve world hunger. She was stabilized and discharged but voluntarily discontinued all her psychiatric medications 6 months ago. Vital signs are within normal limits. Physical examination, electrocardiogram, and baseline laboratory studies, including a comprehensive metabolic panel, thyroid-stimulating hormone, and urine toxicology, are unremarkable. Which of the following is the most appropriate next step in management?
- Initiate cognitive-behavioral therapyCevap
- BInitiate sertraline monotherapy
- CInitiate citalopram and phenelzine concurrently
- DDisclose the diagnosis to her roommate to ensure safety during future attacks
- EInitiate haloperidol for a presumed recurrence of schizophreniform disorder